PubRank
Search
About
Sophie Cypowyj
Author PubWeight™ 27.08
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
Science
2011
6.19
2
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
J Exp Med
2011
3.63
3
Distinct innate immune responses to infection and wounding in the C. elegans epidermis.
Curr Biol
2008
2.19
4
Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Curr Opin Immunol
2010
1.66
5
Antifungal innate immunity in C. elegans: PKCdelta links G protein signaling and a conserved p38 MAPK cascade.
Cell Host Microbe
2009
1.60
6
Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes.
Curr Opin Immunol
2012
1.51
7
Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
Curr Opin Allergy Clin Immunol
2012
1.43
8
An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.
Immunity
2013
1.35
9
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
J Med Genet
2013
1.22
10
Herpes in STAT1 gain-of-function mutation [corrected].
Lancet
2012
1.04
11
Primary immunodeficiencies underlying fungal infections.
Curr Opin Pediatr
2013
1.01
12
Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.
J Allergy Clin Immunol
2012
0.90
13
The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells.
J Biol Chem
2012
0.88
14
Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.
J Leukoc Biol
2013
0.85
15
A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation.
J Clin Immunol
2013
0.81
16
[Innate Lymphoid Cells: new actors of immunity].
Bull Acad Natl Med
2017
0.75